Skip to content
  • Home
  • About Us
    • About
    • Our Mentors
    • Career
    • Blog
    • Newsletters
    • Media
  • COURSES
    • EBCOG Part 1
    • EBCOG Part 2 OSCE
  • FREE LIBRARY
    • EBCOG Part 1 Free Library
    • EBCOG Part 2 OSCE Free Library
  • FREE COUNSELLING
  • CONTACT US
  • Search

My Account

EBCOG Part 1-Drug therapy in obstetrics and gynaecology

EBCOG Part 1-Drug therapy in obstetrics and gynaecology

Time limit: 0

Quiz Summary

0 of 10 Questions completed

Questions:

Information

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 10 Questions answered correctly

Your time:

Time has elapsed

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Categories

  1. Not categorized 0%
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  1. Current
  2. Review
  3. Answered
  4. Correct
  5. Incorrect
  1. Question 1 of 10
    1. Question

    1. With regards to mifepristone:

    A It is a progesterone receptor agonist

    B It is an 11b-dimethyl-amino-phenyl derivative

    C It has a high affinity for progesterone receptors

    D It has a high affinity for glucocorticoid receptors

    E It blocks the progesterone receptors in the myometrium and cervix

    Correct
    Incorrect
  2. Question 2 of 10
    2. Question

    2. Mifepristone:

    A Is absolutely contraindicated in women with adrenal insufficiency

    B Is absolutely contraindicated in women with mild asthma

    C Is absolutely contraindicated in women on anticoagulant therapy

    D Is absolutely contraindicated in women with hypertension

    E Is absolutely contraindicated in women smokers <25 years age

    Correct
    Incorrect
  3. Question 3 of 10
    3. Question

    3.With regards to antihypertensive drug use during pregnancy:

    A Methyldopa is an a1-agonist

    B Methyldopa can cause systemic lupus erythematosus (SLE) like symptoms

    C Methyldopa may cause a positive Coomb’s test

    D Methyldopa may cause a raised serum alanine aminotransferase

    E Methyldopa is contraindicated in women with intrauterine fetal growth restriction (IUGR)

    Correct
    Incorrect
  4. Question 4 of 10
    4. Question

    4.With regards to antihypertensive drugs:

    A Sodium nitroprusside can be safely used during all trimesters of pregnancy

    B Atenolol can be safely used to treat pre-eclampsia during pregnancy

    C Diazoxide can be safely used during pregnancy

    D Angiotensin converting enzyme (ACE) inhibitors can be safely used during

    pregnancy

    E Nifedipine can be safely used during pregnancy

    Correct
    Incorrect
  5. Question 5 of 10
    5. Question

    5.With regards to antihypertensive treatment during pregnancy:

    A Labetalol should be used with caution in women with asthma

    B Labetalol has a positive effect on fetal lung maturation in women with severe hypertension who are distant from term

    C Intravenous labetalol, when used for treating severe hypertension, causes more reflex tachycardia than hydralazine

    D Intravenous hydralazine causes controlled decrease in blood pressure when administered for treatment of severe hypertension

    E Intravenous nitroglycerine in high doses may result in methemoglobinemia

    Correct
    Incorrect
  6. Question 6 of 10
    6. Question

    6.The following abnormalities and drugs are correctly matched:

    A Neural tube defects – sodium valproate

    B Ebstein’s anomaly – lithium

    C Orofacial defects – carbamazepine

    D Limb defects – thalidomide

    E Vaginal adenosis – diethylstilboestrol

    Correct
    Incorrect
  7. Question 7 of 10
    7. Question

    7.Tranexamic acid:

    A Is an antifibrinolytic agent

    B Is used as a third line drug for the treatment of menorrhagia

    C Increases endometrial tissue plasminogen activator activity

    D Reduces menstrual blood loss by 90%

    E Can cause dysmenorrhoea

    Correct
    Incorrect
  8. Question 8 of 10
    8. Question

    8.With regards to heparin:

    A Unfractionated heparin crosses the placenta

    B Low molecular weight heparin (LMWH) increases the risk of fetalhaemorrhage

    C Thrombocytopenia is more common with LMWH compared to unfractionated heparin

    D Unfractionated heparin can cause symptomatic osteoporosis

    E LMWH has a better side effect profile compared to unfractionated heparin

    Correct
    Incorrect
  9. Question 9 of 10
    9. Question

    9.With regards to warfarin and pregnancy:

    A It crosses the placenta

    B It is not a teratogen

    C Epidural anaesthesia can be used if mother is on warfarin

    D Spinal anaesthesia can be used if mother is on warfarin

    E Its use should be avoided after 36 weeks of gestation

    Correct
    Incorrect
  10. Question 10 of 10
    10. Question

    10.With regards to Dextran 70:

    A It can be safely used in pregnancy

    B It can cause an anaphylactoid reaction in the mother

    C It can cause uterine hypotonus

    D It can cause fetal distress

    E It can cause fetal death

    Correct
    Incorrect
monisha2021-03-24T06:52:28+00:00

FAQ
Sign In
Privacy Policy
Copyright Policy
Data and intellectual Policy
Terms and Conditions
Refund Policy

+91 9072900800
+971 54 771 9424 (UAE)

sales@studymrcog.com
info@studymrcog.com

Operations Office:
StudyMRCOG Medical Consultancy (P) Limited.
Door No XIV 90-G, First Floor NKK Plaza
Pannithadam Road, Kechery
Thrissur, Pin-680501, Kerala, India
Phone: +91 4885 299 581

Copyright © StudyEBCOG|All Rights Reserved.|First Ever Global Franchise Partner for EFOG-EBCOG Courses.

Javascript not detected. Javascript required for this site to function. Please enable it in your browser settings and refresh this page.

Go to Top